Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Income from Continuing Operations (2016 - 2025)

Tandem Diabetes Care's Income from Continuing Operations history spans 13 years, with the latest figure at 510000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 165.81% year-over-year to 510000.0; the TTM value through Dec 2025 reached 204631000.0, down 113.23%, while the annual FY2025 figure was 204710000.0, 113.18% down from the prior year.
  • Income from Continuing Operations reached 510000.0 in Q4 2025 per TNDM's latest filing, up from 21165000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 10764000.0 in Q4 2021 to a low of 130556000.0 in Q1 2025.
  • Average Income from Continuing Operations over 5 years is 30110600.0, with a median of 22182500.0 recorded in 2024.
  • Peak YoY movement for Income from Continuing Operations: skyrocketed 161.38% in 2021, then plummeted 944.34% in 2022.
  • A 5-year view of Income from Continuing Operations shows it stood at 10764000.0 in 2021, then crashed by 247.66% to 15894000.0 in 2022, then tumbled by 88.54% to 29967000.0 in 2023, then soared by 102.59% to 775000.0 in 2024, then tumbled by 165.81% to 510000.0 in 2025.
  • Per Business Quant, the three most recent readings for TNDM's Income from Continuing Operations are 510000.0 (Q4 2025), 21165000.0 (Q3 2025), and 52400000.0 (Q2 2025).